Posts Tagged ‘Càncer de fetge’

Thursday April 12th, 2018

Hospital Clínic and IDIBAPS researchers participate in the new European clinical guidelines for the management of hepatocellular carcinoma

Two researchers from the Hepatic Oncology Unit at Hospital Clínic-IDIBAPS have participated in the development of the new clinical practice guidelines for the management of hepatocellular carcinoma developed by the European Association for the Study of the Liver (EASL). It is a consensus document that marks the road map in the diagnosis, treatment and monitoring of this type of cancer, which accounts for 90% of primary liver tumors. Read the rest of this entry »

Comments Closed
Tuesday September 29th, 2015

Dr. Jordi Bruix, new Scientific Director of the Networked Biomedical Research Center for Hepatic and Digestive Diseases

Dr. Jordi Bruix, group leader of the Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD) at Hospital Clínic and IDIBAPS, has been appointed CIBEREHD Scientific Director on the CIBER Standing Committee (dependent on the Carlos III Health Institute) held this morning. Dr. Bruix succeeds Dr. Jaume Bosch, also from the Hospital Clinic of  and the IDIBAPS, who occupied this position since 2006.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Tuesday March 31st, 2015

A pioneering study correlates genetic alterations and environmental factors in liver cancer

IDIBAPS researchers have participated in a pioneering study in hepatocellular carcinoma, the most common liver cancer, in which all the genetic alterations that occur in this type of tumor have been characterized. In an article published in the journal Nature Genetics scientists provide a complete overview of the disease and these genetic alterations associated with the etiology and clinical characteristics, the proposed treatments for patients approved for other cancers, which could be applied in each case. Dr. Josep Maria Llovet, ICREA professor at the IDIBAPS Hepatic Oncology Group and director of the Liver Cancer Program at the Icahn School of Medicine at Mount Sinai (New York), and Dr. Roser Pinyol, researcher at the same group, have participated in this article led by Dr. Jessica Zucman-Rossi, from the INSERM-Paris.

Read the rest of this entry »

Comments Closed
Monday November 22nd, 2010

HEPTROMIC, a new approach to Hepatocellular Carcinoma



HEPTROMIC is the first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma (HCC). It is a 3-year translational research project which aims to solve core problems in the management of HCC, the third most common cause of cancer-related death worldwide. The partners taking part in this initiative have met today in Barcelona in the called kick-off meeting, which officially starts the project. Dr. Josep Maria Llovet, ICREA Research professor at IDIBAPS – Hospital Clínic, and his team lead that project which is meant to change the treatment of this cancer in the next years.

Read the rest of this entry »

Comments Closed